Acadian Asset Management
STLN

Acadian Asset Management’s Starling Oncology STLN Stock Holding History

Acadian Asset Management’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.07M Buy
+567,001
New +$2.38M ﹤0.01% 940
2024
Q2 		– Sell
-38,639
Closed -$60K – 1903
2024
Q1 		$60K Hold
38,639
– – ﹤0.01% 1362
2023
Q4 		$78K Buy
+38,639
New +$67K ﹤0.01% 1397

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management's STLN Position: Q2 2026 in Review

Acadian Asset Management opened a new position in Starling Oncology (STLN) in Q2 2026: 567,001 shares worth $3.07M. The stake represents ﹤0.01% of the portfolio and ranks #940 among its holdings. This is a return to the name: Acadian Asset Management previously reported a position in STLN as recently as Q1 2024.

Acadian Asset Management first reported a position in STLN in Q4 2023 and has held it in 3 quarters since. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Acadian Asset Management held 567,001 shares of Starling Oncology worth $3.07M as of Q2 2026.
  • Starling Oncology was a new Acadian Asset Management position in Q2 2026.
  • Starling Oncology made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #940 holding.
  • Acadian Asset Management first reported a position in Starling Oncology in Q4 2023 and has held it in 3 quarters since.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.